| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Fox-Martin Adaire | CEO and President, Director | C/O EQUINIX, INC., ONE LAGOON DRIVE, REDWOOD CITY | /s/ Samantha Lagocki, POA | 19 Feb 2026 | 0001795624 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | EQIX | Common Stock | Options Exercise | $0 | +2,669 | +18% | $0.000000 | 17,559 | 17 Feb 2026 | Direct | F1 |
| transaction | EQIX | Common Stock | Options Exercise | $0 | +5,297 | +30% | $0.000000 | 22,856 | 17 Feb 2026 | Direct | |
| transaction | EQIX | Common Stock | Sale | $93,483 | -101 | -0.44% | $925.58 | 22,755 | 18 Feb 2026 | Direct | F2, F3 |
| transaction | EQIX | Common Stock | Sale | $746,974 | -806 | -3.5% | $926.77 | 21,949 | 18 Feb 2026 | Direct | F2, F4 |
| transaction | EQIX | Common Stock | Sale | $373,719 | -403 | -1.8% | $927.34 | 21,546 | 18 Feb 2026 | Direct | F2, F5 |
| transaction | EQIX | Common Stock | Sale | $469,886 | -506 | -2.3% | $928.63 | 21,040 | 18 Feb 2026 | Direct | F2, F6 |
| transaction | EQIX | Common Stock | Sale | $161,700 | -174 | -0.83% | $929.31 | 20,866 | 18 Feb 2026 | Direct | F2, F7 |
| transaction | EQIX | Common Stock | Sale | $260,521 | -280 | -1.3% | $930.43 | 20,586 | 18 Feb 2026 | Direct | F2, F8 |
| transaction | EQIX | Common Stock | Sale | $186,417 | -200 | -0.97% | $932.08 | 20,386 | 18 Feb 2026 | Direct | F2, F9 |
| transaction | EQIX | Common Stock | Sale | $112,051 | -120 | -0.59% | $933.76 | 20,266 | 18 Feb 2026 | Direct | F2, F10 |
| transaction | EQIX | Common Stock | Sale | $112,120 | -120 | -0.59% | $934.33 | 20,146 | 18 Feb 2026 | Direct | F2, F11 |
| transaction | EQIX | Common Stock | Sale | $106,811 | -114 | -0.57% | $936.94 | 20,032 | 18 Feb 2026 | Direct | F2, F12 |
| transaction | EQIX | Common Stock | Sale | $80,726 | -86 | -0.43% | $938.67 | 19,946 | 18 Feb 2026 | Direct | F2, F13 |
| transaction | EQIX | Common Stock | Sale | $385,125 | -410 | -2.1% | $939.33 | 19,536 | 18 Feb 2026 | Direct | F2, F14 |
| transaction | EQIX | Common Stock | Sale | $141,027 | -150 | -0.77% | $940.18 | 19,386 | 18 Feb 2026 | Direct | F2, F15 |
| transaction | EQIX | Common Stock | Sale | $301,339 | -320 | -1.7% | $941.68 | 19,066 | 18 Feb 2026 | Direct | F2, F16 |
| transaction | EQIX | Common Stock | Sale | $188,555 | -200 | -1% | $942.77 | 18,866 | 18 Feb 2026 | Direct | F2, F17 |
| transaction | EQIX | Common Stock | Sale | $226,520 | -240 | -1.3% | $943.84 | 18,626 | 18 Feb 2026 | Direct | F2, F18 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | EQIX | Restricted Stock Units | Options Exercise | $0 | -2,669 | -50% | $0.000000 | 2,668 | 17 Feb 2026 | Common Stock | 2,669 | $0.000000 | Direct | F19, F20 |
| transaction | EQIX | Restricted Stock Unit | Award | $0 | +10,594 | $0.000000 | 10,594 | 17 Feb 2026 | Common Stock | 10,594 | $0.000000 | Direct | F20, F21 | |
| transaction | EQIX | Restricted Stock Unit | Options Exercise | $0 | -5,297 | -50% | $0.000000 | 5,297 | 17 Feb 2026 | Common Stock | 5,297 | $0.000000 | Direct | F20, F21 |
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
| Id | Content |
|---|---|
| F1 | 32.243 shares acquired under the Equinix, Inc. Employee Stock Purchase Plan on February 13, 2026. |
| F2 | Shares were sold pursuant to a 10b5-1 Trading Plan in order to raise funds to pay the required withholding tax pursuant to the vesting of RSUs. |
| F3 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $925.00 to $925.95, inclusive. The reporting person undertakes to provide to Equinix, Inc, any security holder of Equinix Inc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 4 through 18 to this Form 4. |
| F4 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $926.01 to $927.00 inclusive. |
| F5 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $927.04 to $928.00 inclusive. |
| F6 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $928.07 to $929.07 inclusive. |
| F7 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $929.13 to $929.55 inclusive. |
| F8 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $930.27 to $930.72 inclusive. |
| F9 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $931.85 to $932.29 inclusive. |
| F10 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $933.18 to $934.09 inclusive. |
| F11 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $934.30 to $934.44 inclusive. |
| F12 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $936.60 to $937.29 inclusive. |
| F13 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $937.82 to $938.75 inclusive. |
| F14 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $938.90 to $939.90 inclusive. |
| F15 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $940.00 to $940.51 inclusive. |
| F16 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $941.53 to $942.41 inclusive. |
| F17 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $942.60 to $942.89 inclusive. |
| F18 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $943.71 to $943.86 inclusive. |
| F19 | On March 7, 2024 the reporting person was granted performance restricted stock units, the vesting of which was subject to both continued service and the attainment of certain AFFO, Revenue and EBITDA targets for 2024. The Compensation Committee certified the degree to which the targets were achieved, therefore 50% of the award vested on February 15, 2025, 25% will vest on February 15, 2026 and the remaining 25% will vest on February 15, 2027, subject solely to continued service. |
| F20 | Restricted stock unit award expires upon reporting person's termination of service. |
| F21 | On March 11, 2025 the reporting person was granted performance restricted stock units, the vesting of which was subject to both continued service and the attainment of certain AFFO, Revenue and EBITDA targets for 2025. The Compensation Committee certified the degree to which the targets were achieved, therefore 50% of the award vested on February 15, 2026, 25% will vest on February 15, 2027 and the remaining 25% will vest on February 15, 2028, subject solely to continued service. |